Growth Potential Small to mid-sized medtech player with 51-200 employees and annual revenue in the low to mid single digits suggests ample room for upsell of advanced microfluidics, Lab-on-a-Chip capabilities, and integrated quality systems to scale manufacturing for point-of-care devices.

Haemostasis Focus Flagship microINR system targets stringent anti-vitamin K OAT monitoring, creating opportunities to position complementary disposables, accessories, and data integration solutions to clinics, hospitals, and home-testing channels.

Quality & IP Patent-pending proprietary technology and high quality standards can be leveraged to pursue partnerships or OEM arrangements with larger medtechs seeking innovative, defensible microfluidic platforms and validated performance.

Tech & Cloud Existing tech stack and cloud-ready infrastructure (CI/CD potential via PHP/Nginx/Apache ecosystem) open doors for offering secure data capture, remote monitoring, and software updates as a service to customers and partners.

Strategic Partnerships Geographic positioning in Basque Country with global market parallels to peers and a focused niche in point-of-care haemostasis presents a path for distribution partnerships, contract manufacturing, and joint development with other medtech firms.